Mei Pharma

7 email addresses found for meipharma.com
{first}.{last}@meipharma.com
7 email addresses
http://clsvc.com/mei-pharma-announces-topline-data-from-phase-i-clinical-trial-of-mitochondrial-inhibitor-drug-candidate-me-344/ October 10, 2015
http://clsvc.com/mei-pharma-identifies-potential-biomarker-for-pracinostat-in-bladder-cancer/ October 10, 2015
http://clsvc.com/mei-pharma-initiates-clinical-study-of-mitochondrial-inhibitor-drug-candidate-me-344-in-small-cell-lung-and-ovarian-cancers/ October 10, 2015
http://clsvc.com/mei-pharma-receives-orphan-status-for-lead-drug-candidate-pracinostat-for-treatment-of-acute-myeloid-leukemia/ October 10, 2015
http://clsvc.com/mei-pharmas-mitochondrial-inhibitor-me-344-shows-preliminary-evidence-of-single-agent-activity-in-first-in-human-clinical-study/ October 10, 2015
http://consilium-comms.com/news-insights/client-news/client-news/2017/helsinn-group-and-mei-pharma-announce-upcoming-presentations-of-gene-mutation-and-clinical-response-data August 8, 2018
http://emjreviews.com/press/helsinn-group-and-mei-pharma-announce-first-patient-dosed-in-pivotal-phase-3-study-of-pracinostat-and-azacitidine-in-acute-myeloid-leukemia September 9, 2017
http://headlines204.rssing.com/chan-13731578/all_p1039.html July 7, 2018
http://helsinn.com/news-and-events/helsinn-group-and-mei-pharma-announce-first-patient-dosed-in-phase-2-dose-optimization-study-of-pracinostat-and-azacitidine-in-myelodysplastic-syndrome June 6, 2018
http://helsinn.com/news-and-events/helsinn-group-and-mei-pharma-announce-first-patient-dosed-in-pivotal-phase-3-study-of-pracinostat-and-azacitidine-in-acute-myeloid-leukemia June 6, 2018
http://helsinn.com/news-and-events/helsinn-group-and-mei-pharma-enter-strategic-agreement-for-the-development-of-pracinostat-for-the-treatment-myeloid-leukemia-and-other-diseases November 11, 2016
http://helsinn.com/news-and-events/helsinn-group-and-mei-pharma-report-prolongation-of-survival-results-from-phase-2-clinical-study-of-pracinostat-and-azacitidine-in-acute-myeloid-leukemia December 12, 2016
http://investor.meipharma.com/2013-10-25-mei-pharma-announces-pricing-of-public-offering-of-common-stock September 9, 2018
http://investor.meipharma.com/2013-10-25-MEI-Pharma-Announces-Pricing-of-Public-Offering-of-Common-Stock April 4, 2015
http://investor.meipharma.com/2015-11-11-mei-pharma-to-present-at-stifel-healthcare-conference December 12, 2015
http://investor.meipharma.com/2015-12-07-mei-pharma-announces-positive-results-from-phase-ii-study-of-pracinostat-in-acute-myeloid-leukemia-plans-to-initiate-phase-iii-registration-study December 12, 2015
http://investor.meipharma.com/2017-09-19-mei-pharma-to-present-at-cantor-fitzgerald-global-healthcare-conference July 7, 2018
http://manufacturing.helsinn.com/news-and-events/helsinn-group-and-mei-pharma-enter-strategic-agreement-for-the-development-of-pracinostat-for-the-treatment-myeloid-leukemia-and-other-diseases March 3, 2017
http://news.sys-con.com/node/3022399 July 7, 2017
http://nirisandiego.camp7.org/board October 10, 2016
http://nirisd.org June 6, 2016
http://perssupport.nl/persbericht/116237/helsinn-group-and-mei-pharma-report-prolongation-of-survival-results-from-phase-2-clinical-study-of-pracinostat-and-azacitidine-in-acute-myeloid-leukemia September 9, 2017
http://presseportal.ch/de/pm/100007032/100795145 September 9, 2017
http://presseportal.ch/de/pm/100007032/100796566 September 9, 2017
http://presseportal.de/pm/56585/3473913 September 9, 2017
http://santelog.com/actualites-sante-nasdaq/helsinn-group-and-mei-pharma-announce-first-patient-dosed-pivotal-phase-3 August 8, 2017
Show more results

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about meipharma.com

Industry: Science

Language of the website: English